The safety and efficacy of adjusted-dose enoxaparin (clexane) in pregnant patients with increased risk for venous thrombo-embolic disease: a retrospective analysis of clinical and laboratory data

Files in this item

This item appears in the following Collection(s)

Search WIReDSpace


Browse

My Account